These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33933782)

  • 1. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.
    Okada R; Maruoka Y; Furusawa A; Inagaki F; Nagaya T; Fujimura D; Choyke PL; Kobayashi H
    Bioconjug Chem; 2019 Oct; 30(10):2624-2633. PubMed ID: 31498995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.
    Kato T; Okada R; Furusawa A; Inagaki F; Wakiyama H; Furumoto H; Okuyama S; Fukushima H; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2021 Nov; 20(11):2262-2273. PubMed ID: 34518299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Effectiveness of IgG Antibody versus F(ab')
    Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
    Furumoto H; Okada R; Kato T; Wakiyama H; Inagaki F; Fukushima H; Okuyama S; Furusawa A; Choyke PL; Kobayashi H
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
    Kobayashi H; Furusawa A; Rosenberg A; Choyke PL
    Int Immunol; 2021 Jan; 33(1):7-15. PubMed ID: 32496557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.
    Nakajima T; Sano K; Choyke PL; Kobayashi H
    Theranostics; 2013; 3(6):357-65. PubMed ID: 23781283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
    Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
    Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
    Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.
    Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
    Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.